SCHEMBL14374646

SCHEMBL14374646

CCc1nc(=O)n(C)c2c1ccc1ccncc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ MAT2A P31153 1/20 0.34
▸ HIPK2 Q9H2X6 1/20 0.33
▸ ADORA3 P0DMS8 2/20 0.32
▸ ADORA2A P29274 2/20 0.32
▸ ADORA1 P30542 2/20 0.32
▸ TOP2A P11388 1/20 0.32
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ DYRK1A Q13627 2/20 0.32
▸ KDM5A P29375 1/20 0.32
▸ AURKA O14965 1/20 0.32
▸ DAPK3 O43293 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ ROCK2 O75116 1/20 0.32
▸ CHEK2 O96017 1/20 0.32
▸ CDK1 P06493 1/20 0.32
▸ PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14374231 0.89 MAPK1 (0.39) HTR2CHTR2AHTR2BMAT2AADORA3
SCHEMBL14347562 0.81 HTR2A (0.36) HTR2CHTR2AHTR2BHIPK2ADORA3
SCHEMBL14374782 0.74 PDE10A (0.41) HTR2CHTR2AHTR2BMAT2AMAPT
SCHEMBL14374643 0.74 CCR1 (0.40) HTR2CHTR2AHTR2BMAT2AMAPK1
SCHEMBL14374177 0.71 DYRK1A (0.38) HTR2CHTR2AHTR2BHIPK2ADORA3
SCHEMBL14374967 0.70 CYP1A2 (0.35) HTR2CHTR2AHTR2BHIPK2DYRK1A
SCHEMBL14347542 0.69 ROCK2 (0.36) HTR2CHTR2AHTR2BADORA3ADORA2A
SCHEMBL25703670 0.68 TOP2A (0.54) HTR2CHTR2AHTR2BTOP2AMAPT
SCHEMBL23169453 0.67 PDE3B (0.42) HTR2CHTR2AHTR2BDYRK1ACLK1
SCHEMBL14374602 0.65 MAT2A (0.49) MAT2AMAPK1RORCMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312211-B2 Pryanone compounds useful as reversible inhibitors of cysteine proteases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2007-12-25 — — US disclosed
Send feedback